Literature DB >> 23188042

Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.

Chantal Lambert-Harris1, Elizabeth C Saunders, Mark P McGovern, Haiyi Xie.   

Abstract

OBJECTIVES: There is widespread recognition that services to persons with co-occurring substance use and psychiatric disorders should be accessible, yet most persons with these disorders do not receive care for both problems. Estimates of available services vary widely and have not examined potential variation by level of care.
METHODS: The present study samples 180 community addiction treatment programs and utilizes a standardized observational assessment of these programs using the dual diagnosis capability of addiction treatment (DDCAT) index. By level of care, the sample consisted of 53 outpatient programs, 50 intensive outpatient programs, and 77 residential programs.
RESULTS: Overall, approximately 81.1% of programs across levels of care offered addiction-only services, 18.3% dual diagnosis capable services, and less than 1% dual diagnosis enhanced services. Relative to residential and intensive outpatient programs, outpatient programs were more likely to have greater dual diagnosis capability (dual diagnosis capable services). Outpatient programs scored significantly higher on the DDCAT dimensions associated with program policies and continuity of care. Specific DDCAT benchmark items revealing detailed differences were found in these dimensions and specific assessment and treatment practices. Access to physician-prescriber or to psychotropic medications did not differ by level of care.
CONCLUSIONS: The findings suggest that across levels of care, addiction-treatment systems and programs must continue to improve capacity for patients with co-occurring disorders. The application of a standardized, objective, and observational instrument may be useful to guide and measure the effectiveness of these efforts.

Entities:  

Mesh:

Year:  2013        PMID: 23188042     DOI: 10.1097/ADM.0b013e318276e7a4

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  10 in total

1.  Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.

Authors:  Pia M Mauro; C Debra Furr-Holden; Eric C Strain; Rosa M Crum; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2016-04-07       Impact factor: 4.492

Review 2.  Sex and gender differences in substance use disorders.

Authors:  R Kathryn McHugh; Victoria R Votaw; Dawn E Sugarman; Shelly F Greenfield
Journal:  Clin Psychol Rev       Date:  2017-11-10

3.  Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.

Authors:  James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  Implement Res Pract       Date:  2021-09-17

4.  Wait No Longer: Reducing Medication Wait-Times for Individuals with Co-Occurring Disorders.

Authors:  James H Ford; Deepika Rao; Aaron Gilson; Arveen Kaur; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  J Dual Diagn       Date:  2022-04-07

5.  Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.

Authors:  Elizabeth Evans; Howard Padwa; Libo Li; Veronique Lin; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2015-07-15

6.  Sustainment of Integrated Care in Addiction Treatment Settings: Primary Outcomes From a Cluster-Randomized Controlled Trial.

Authors:  Helene Chokron Garneau; Mehret T Assefa; Booil Jo; James H Ford; Lisa Saldana; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2021-08-04       Impact factor: 3.084

7.  Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review.

Authors:  Ray Alsuhaibani; Douglas Cary Smith; Richard Lowrie; Sumayah Aljhani; Vibhu Paudyal
Journal:  BMC Psychiatry       Date:  2021-04-23       Impact factor: 3.630

Review 8.  Cocaine Use Disorder (CUD): Current Clinical Perspectives.

Authors:  Elizabeth K C Schwartz; Noah R Wolkowicz; Joao P De Aquino; R Ross MacLean; Mehmet Sofuoglu
Journal:  Subst Abuse Rehabil       Date:  2022-09-03

9.  Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic.

Authors:  Fatima Mougharbel; Hugues Sampasa-Kanyinga; Brandon Heidinger; Kim Corace; Hayley A Hamilton; Gary S Goldfield
Journal:  Front Public Health       Date:  2021-06-25

10.  Implementing integrated services in routine behavioral health care: primary outcomes from a cluster randomized controlled trial.

Authors:  Mehret T Assefa; James H Ford; Eric Osborne; Amy McIlvaine; Ahney King; Kevin Campbell; Booil Jo; Mark P McGovern
Journal:  BMC Health Serv Res       Date:  2019-10-24       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.